chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Dizziness at time of injection, migraine the rest of the day.  Nausea and slight dizziness throughout the week.  Left work early 1/20/21 with nausea and vertigo, began short term disability.  Contacted PCP for antibiotics thinking I had an ear infection; upon completion of antibiotic and continued symptoms, contacted PCP again and was told to see a ENT.  After testing was then referred to a neurologist.
Inconsolable crying for 2 hours and 50 minutes started within 2 hours of receiving vaccinations, right leg became swollen, red and hot to the touch within just a few hours also. I began to notice child waking up gasping for breath within 2 weeks, this led to a sleep study and diagnosis of obstructive sleep apnea at 11 months of age.
Started with an itchy rash that spread on my right leg. I went to dermatologist on  9/29/2021 and was told I had lichen planus. I have never had it before or anything like it.
I have noticed a ringing in my ears consistently since June, and in fact, am noticing it right now as I right this. I had not noticed this at all prior to taking the vaccine.
About 10 minutes after administering patient's second dose of the Pfizer COVID vaccine, patient's father called attention saying "she's not doing well."  Patient passed in and out of consciousness for about 5-10 minutes.  At that time EMS was call and patient regained consciousness.  She reported loss of vision, thirst, and feeling hot.  EMS arrived, checked vitals, and patient left on own accord with parent.
Had vaccine at 15:00. Urticaria, flushing, vertigo, weakness at 15:15.
Pt recvd vax 16NOV92 & the next day devel swelling @ the inject site, low grade fever & myalgia; No further details were provided;
tightness in left leg muscles; This case was reported by a consumer via call center representative and described the occurrence of muscle tightness in a 81-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Concurrent medical conditions included thrombosis leg.   On 4th February 2023, the patient received the 1st dose of Shingrix. On 5th February 2023, 1 days after receiving Shingrix, the patient experienced muscle tightness. On an unknown date, the outcome of the muscle tightness was not recovered/not resolved.   It was unknown if the reporter considered the muscle tightness to be related to Shingrix.     Additional Information: GSK receipt date: 06-FEB-2023 Reporter's comment: The patient got his first Shingrix vaccine 2 days ago.  The patient stated that the follow day his left leg muscles started to get really tight.  The patient symptoms were not resolved yet.  The reporter did not consent to follow-up.
102 fever that wouldn't break until about 10 hrs later, severe nausea and headaches, dizziness, extreme body pain
Medical assistant had asked parent to put sibling on the bed and the wrong patient was given the wrong set of vaccines.
A 61 year old man received an induction course and maintenance therapy with OncoTICE since August 2002. The patient had tolerated the OncoTICE instillations well, with no reported problems. At a dental appointment in March 2004, there were no abnormalities noted. Reportedly in June 2004, his dentist noted that the patient's gums were red and sloughing.
Day of shot had a welt at injection site as well as warm to the touch. Went away after a couple days. Welt, itchiness, redness, and warm to the touch appeared again a week after first moderna shot.
exacerbation of existing C8 peripheral neuropathy which has not resolved. muscle soreness and tenderness which was acute for over a month, which has lessened, but still present.
Breakthrough case admission after three vaccines Janssen 4/9/21 Lot# 042A21A;  Janssen 12/3/21 Lot# 1822811;  Pfizer 6/7/22 Lot# FG3527
After receiving the vaccine approx. 1 hour he notice redness ant itching at the top/middle of chest.  Area approx. 3 X 3. Area was red and warm not hot and not much warmer than surrounding area.  Denied SOB or swelling in mouth or chest. Denied itching elsewhere in body.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 78-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 04Apr2022 as dose 4 (booster), single (Batch/Lot number: unknown) at the age of 77 years, in right arm for covid-19 immunisation; coviD-19 vaccine mrna (mrna 1273) (MODERNA COVID-19 VACCINE), on 04Feb2021 as dose 1, single (Batch/Lot number: unknown), in right arm, on 04Mar2021 as dose 2, single (Batch/Lot number: unknown), in right arm and on 27Aug2021 as dose 3 (booster), single (Batch/Lot number: unknown), in right arm for covid-19 immunisation. The patient's relevant medical history included: "High BP" (unspecified if ongoing); "Interchange of vaccine products" (unspecified if ongoing), notes: Dose: 4 Pfizer, Dose: 3, 2, 1 Moderna COVID-19 vaccine. Concomitant medication(s) included: ATORVASTATIN. The following information was reported: COVID-19 (medically significant), DRUG INEFFECTIVE (medically significant), outcome "unknown" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (2022) Negative, notes: Tested negative day 6. Tested negative day 5. On day 9 symptoms returned and tested positive again; (2022) Negative, notes: Tested negative day 6. Tested negative day 5. On day 9 symptoms returned and tested positive again; (2022) Positive, notes: Tested negative day 6. Tested negative day 5. On day 9 symptoms returned and tested positive again. Therapeutic measures were taken as a result of covid-19, drug ineffective. Clinical course: Antiviral details product Paxlovid: COVID 19 Treatment. Treatment start date: 03May2022 and stop date: 08May2022. After finishing 2nd day dose pack symptoms improved. Tested negative day 6. Tested negative day 5. On day 9 symptoms returned and tested positive again. No known allergies. Device timestamp: 12May2022.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Patient is a 20 y/o Male received the MODERNA vaccine on 24 Mar. He started developing substernal chest pain the day after his vaccination. Presented to the clinic with worsening chest pain and was in severe pain upon presentation. ST elevations noted on lateral leads with depression in anterior leads with elevated troponins. Had CT, echo, and cath which showed mild inflammation and normal cardiac cath. Patient diagnosed with myocarditis.
20FEB extremly swollen lymph nodes under ears; 22FEB appearance of pinpoint rash; stomach, legs, arms; 25FEB sore, swollen knees lt & rt; 25FEB 8MAR diminishing knee discomfort, while hands, wrists & elbows were sore;
Mom notice on right leg. Knot with red fever 3  days after. Went to Doctor and was given antibiotic.
received the Pfizer covid vaccine, and developed shingles; depression; being discourage; in pain; This is a spontaneous report received from contactable reporter(s) (Other HCP and Consumer or other non-HCP), Program ID:   A 43-year-old female patient received BNT162b2 (BNT162B2), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Rheumatoid arthritis" (ongoing). Concomitant medication(s) included: XELJANZ XR oral taken for rheumatoid arthritis, start date: 27Nov2022 (ongoing).  The following information was reported: HERPES ZOSTER (non-serious), outcome "unknown", described as "received the pfizer covid vaccine, and developed shingles"; DEPRESSION (non-serious), outcome "unknown"; DISCOURAGEMENT (non-serious), outcome "unknown", described as "being discourage"; PAIN (non-serious), outcome "unknown", described as "in pain".  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Low-grade fever and headache. Acetaminophen, ibuprofen. Lasted ~24 hours
"few muscle aches"; "I was tired, nothing dramatic"; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA ("few muscle aches") and FATIGUE ("I was tired, nothing dramatic") in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In February 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MYALGIA ("few muscle aches") and FATIGUE ("I was tired, nothing dramatic"). At the time of the report, MYALGIA ("few muscle aches") and FATIGUE ("I was tired, nothing dramatic") outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications was not provided by the reporter.  Treatment information was not provided.   This case was linked to MOD-2021-379667 (Patient Link).
Diagnosed it as a staph infection; Diagnosed it as scabies / Scaly scab-like form; Pain; still suffering with new blisters; scaly scabs; Extensive shingles-like reactions all over my body/ blister-like reaction/shingleslike blisters; This case was reported by a consumer via call center representative and described the occurrence of staphylococcal infection in a 61-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix with an associated reaction of pyrexia (1st dose received on 19th September 2019, refer case US2020AMR059707).   On 13th January 2020, the patient received the 2nd dose of Shingrix. On 13th January 2020, immediately after receiving Shingrix, the patient experienced vesicular rash. On an unknown date, the patient experienced staphylococcal infection (serious criteria GSK medically significant), scabies, pain, blister and skin scaly. On an unknown date, the outcome of the staphylococcal infection and pain were unknown and the outcome of the scabies, vesicular rash, blister and skin scaly were not recovered/not resolved.   It was unknown if the reporter considered the staphylococcal infection, scabies, vesicular rash, pain, blister and skin scaly to be related to Shingrix.  Additional details were provide as follows: This case was reported by patient herself. Right after vaccination, the patient had extensive shingles-like reactions all over my body and immediately met her primary care doctor. The primary care physician diagnosed it as a staph infection, prescribed antibiotics and also recommended her to follow up with a dermatologist.  There was no improvement to the patient's condition even after completing the antibiotic treatment.  As the pain and blister-like reaction all over my body was still persistent even after 10 days, the patient could met with a dermatologist who diagnosed it as scabies and prescribed medication for scabies.  After suffering for 2 more weeks, the patient could get an appointment with another dermatologist as the patient was suspicious and not convinced of the diagnosis of scabies. Also, the treatment prescribed for scabies did not work either. This time, the 2nd dermatologist did not have a diagnosis but prescribed a blood test for an auto-immune disorder.  The blood tests were completed, with a negative result and there was no indication of an auto-immune issue. The dermatologist also recommended a biopsy but the shingles like blisters which turn into a scaly scab-like form, persist even till the time of reporting, were small and had not lent themselves to biopsy.  The dermatologist also did mention that, they were noticing some strange reactions to Shingrix.  The patient wanted to know, that after many months of no clear diagnosis and still suffering with new blisters forming every few days and turning into scaly scabs. This case has been linked with case US2020AMR059715, reported by the same reporter.
3 days after injection the site became very swollen, warm, and very sore covering  a 4 1/2 inch diameter
Headache,  hot and cold (no actual temperature) joints hurt, muscles hurt.   I STILL have issues with my right arm getting tingly feeling and can't sleep on it. Had abnormal tightness in my chest, and called my PCP, they said it had too too long after the shot (only 10 days) that it was not related! I had just about every side affect if not all of them!
did not feel good; felt very sore; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (did not feel good) and MYALGIA (felt very sore) in a 55-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No medical history was reported.  Concomitant products included VITAMINS NOS for an unknown indication.    In July 2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MALAISE (did not feel good) and MYALGIA (felt very sore). The patient was treated with ACETAMINOPHEN for Adverse event, at a dose of 1 dosage form. At the time of the report, MALAISE (did not feel good) and MYALGIA (felt very sore) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.     He had called with a medical inquiry about his son who received the first dose of the Moderna COVID 19 vaccine in July, 2021. His son felt very sore and did not feel good for a couple days. He didn't have information on lot number and vaccination site. He heard that there are more side effects on average after the 2nd dose compared to the 1st dose. His son was committed to get the 2nd dose, but he's worried that there might be severe reactions for his son from the 2nd dose. He's more concerned as his wife passed away from kidney cancer. His son experienced the virus 6 to 8 weeks before vaccination. His son got quite sick at that point and recovered.   This case was linked to US-MODERNATX, INC.-MOD-2021-127618, US-MODERNATX, INC.-MOD-2021-127619 (E2B Linked Report).   Reporter did not allow further contact; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-127618: US-MODERNATX, INC.-MOD-2021-127619:
Pain in administration arm (left deltoid) developed within 6 hours and moved toward chest area (armpit area).  Has not moved.  Using motrin 800mg every 6 hours.
Pt c/o shock like sensations in his (L) UE that radiate to his hand. At the time of onset, approximately 2 weeks after the injection, the pt said he did not experience any numbness or pain. Coincidentally, he saw a physician re an unrelated matter. The dates of visit (12/5/08) the physician told the pt the sensation would stop.
This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Still having headaches (second shot on 12th)) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced HEADACHE (Still having headaches (second shot on 12th)). At the time of the report, HEADACHE (Still having headaches (second shot on 12th)) outcome was unknown.            No concomitant medications were reported.  No laboratory details were  provided.  No treatment medications were reported.  Action taken with mRNA-1273 in response to the events was not applicable.
Patient woke up with pleuritic chest and back pain, shortness of breath, chills, temp 98-99 degrees F, body aches, sore arms bilaterally, "dizzy", mild rhinorrhea, "weak", chest tightness.
10 days after vaccine 12/9/04 developed left wrist pain, sore, popping, painful, 12/13/04 developed bil. ankle pain right, bruised like. 12/15/04 headache dull, still had swollen sore wrist, ankles puffy, fingers sore and swollen. 12/15/04 right knee swollen, 12/17/04 could barely move. 11/17/04 saw Dr, Rx with abx, tender fingers persists since 12/22/04.
swelling and rash around injection sight spreading larger as time goes on with pain and het at site.
Flu shot 11/29. On 12/8/12 - numbness in toes/feet/legs. Decrease leg strength by 12/2 & numbness in hands. Decreased reflexes. Saw primary care dr 12/12/12. Transferred to medical center on 12/14/12. Test on spinal fluid 12/18/12 (+) for Guillain Barre -> IV.IG started.
For at least the past two weeks I have developed constant pulsalatile tinnitus, mainly in my left ear, possibly in the right but not sure. Definitely all the time in my left. Didn?t have this before the vaccine.
This case was reported by a lawyer and described the occurrence of arthralgias in a male subject of unspecified age who was vaccinated with LYMErix for prophylaxis. A physician or other health care professionals has not verified this report. On an unspecified date the subject received dose of LYMErix (unknown). On an unspecified date after vaccination with LYMErix, the subject experienced arthalgias, fatigue, burning pain, cramping, fevers, rashes, swollen joints, headaches, numbness, vision problems, hearing problems, rheumatologic, neurologic and/or cognitive impairment of an autoimmune, immune-medicated or other mechanism decreased activities of daily life and decreased ability to participate in recreational activities. At the time of reporting the outcome of the events was unspecified. This information was received via a Statement of Injuries. Follow up information was received on 28 February via medical records. The subject had a complex medical history including a "crush injury"/ neck injury in 1980, thoracic outlet syndrome, three carpal tunnel release surgeries, sensory neuroma of the dorsal right hand treated with neurolysis, severe headaches including migraines (onset prior to August 1998), a knee operation, and what appeared to be "partial removal of the first ribs bilaterally". Prior to December 1994 he underwent two cervical fusions (including cervical fusion of C6-7 with complete obliteration of the intervertebral space), thoracotomy, three ulnar nerve surgeries, lumbar fusion/ laminectomy, and arthoscopy of both knees. On 01 May 2002, the subject underwent diagnostic testing due to severe back pain, with findings including mild lumbar spinal stenosis and moderate central spinal stenosis. The subject presented to the emergency room and was hospitalized on 03 June 2004 with an admitting diagnosis of cerebrovascular accident, rule out radiculopathy. Symptoms at the time of admission included left arm weakness and numbness and inability to control movement, and the subject reported a history of chronic pain secondary to a cervical/ lumbar fusion, depression, Lyme disease, and migraines. He was discharged on 04 June 2004. The events of depression, migraines, cervical/ lumbar fusion were assessed to be medical history, and the possible diagnosis of cerebrovascular accident was not confirmed. Therefore, these are assessed to be incidental findings based upon medical review.
This spontaneous report as received from a certified medical assistant refers to a patient of unknown age and gender. The patient's medical history and concurrent conditions were not reported. In June 2017, the patient was vaccinated with the improperly stored (in 7.2 degrees Fahrenheit for 30 minutes) dose of PROQUAD (for prophylaxis, lot # M014301, albumin status rHA, expiration date 22-SEP-2017; dose and route of administration were not reported) that was reconstituted with the properly stored sterile diluent. Data logger was involved. No previous temperature excursion and no adverse event (reported as no symptoms) were reported. This is one of two reports received from the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1706USA008497.
one or two colds.; was thought as going to die; Initial information received on 17-Oct-2020 regarding an unsolicited valid non-serious case from a consumer (patient) via social media.  This case is linked to case ID: 2020SA294179, 2020SA294195, 2020SA294181, 2020SA294133, 2020SA294183, 2020SA294184, 2020SA294185, 2020SA294186, 2020SA294187, 2020SA294188, 2020SA294189, 2020SA294190, 2020SA294191, 2020SA294192, 2020SA294193, 2020SA294194, 2020SA294180.  This case involves a patient of unknown demographics who thought as going to die (feeling abnormal) and had one or two colds (nasopharyngitis), after receiving INFLUENZA VACCINE.  The patient's medical history, past medical treatments, vaccinations, concomitant medications and family history were not provided.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (batch number and expiration date not reported) via an unknown route in unknown administration site for prophylactic vaccination.  On an unknown date, the patient thought as going to die (feeling abnormal) which was way over 20 years ago and had one or two colds (nasopharyngitis) (non-serious event) (unknown latency) following the administration of INFLUENZA VACCINE. The patient was old now and was considering taking it because of COVID-19 (corona virus disease-2019).  No laboratory data reported.  It was not reported if the patient received a corrective treatment.  At the time of report, the outcome was unknown for the events.  There will be no information on the batch number for this case.
Flu-like symptoms; Caught the flu; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu-like symptoms) and INFLUENZA (Caught the flu) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (Flu-like symptoms) and INFLUENZA (Caught the flu). At the time of the report, INFLUENZA LIKE ILLNESS (Flu-like symptoms) and INFLUENZA (Caught the flu) outcome was unknown. Not Related      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided. Treatment information was not provided.
broken bones; Warm body; arm pain; headache; A spontaneous report  was received from a consumer, concerning himself, a male patient, born in 1947 who received Moderna's COVID-19 Vaccine (mRNA-1273) and experienced warm body, broken bones, arm pain and headache.  The patient's medical history was not provided. Concomitant medications were not provided.  On 20 Jan 2021, the patient received their first of the two planned doses of mRNA-1273 (lot number: 020L270A) for the prophylaxis of COVID-19 infection.  On Sunday (24 Jan 2021), the patient experienced warm body, broken bones, arm pain and headache.  The events of warm body, broken bones, arm pain and headache were considered to be serious with criteria of Other.  Therapeutic measures included were unknown.  Action taken with the second dose of mRNA-1273 in response to the event was not reported.  The outcome of the events warm body, broken bones, arm pain and headache was unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
This is a spontaneous report obtained from a contactable health care professional through a Pfizer sales representative. A 16 year old female patient received, on an unspecified date, TRUMENBA 0.5 ml, single dose and MENACTRA. Relevant medical history and concomitant medications were unknown. On an unspecified date, after the vaccinations, the patient passed out for a few seconds. No further information provided.
Symptoms started aprox a week after the vaccination with areas of joint and neck pain progressively getting much worse. Although at the time immediately following the injection patient's BP dropped, she became pale and fainty and her throat felt like it was closing up.